drugset / Trial / NCT00355953

Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women

NCT00355953

Phase 2/3 Completed 400 enrolled University of Messina
RandomizedParallel-groupDouble-blindTreatment

Summary

The present research program is proposed deepening some pharmacological effects of the genistein therapy in order to individualize alternative treatments to the conventional hormonal replacement therapy useful to reduce the cardiovascular morbidity and mortality and the osteoporotic consequences in postmenopausal women.

Timeline

Start
2003-01
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Genistein Other / unclassified 54 mg

Indications

No indication recorded.